Unlocking the full potential of complement therapeutics through the power of selectivity.
2 - 10
π° $100M Private Equity Round on 2022-04
October 4
Leads medical affairs strategy for European market at Dianthus Therapeutics.
πͺπΊ Anywhere in Europe β Remote
π° $100M Private Equity Round on 2022-04
β° Full Time
π Senior
π Director
July 25
Lead drug safety strategy at a biotechnology company focused on monoclonal antibodies.
πΊπΈ United States β Remote
π° $100M Private Equity Round on 2022-04
β° Full Time
π Senior
π¨ββοΈ Medical Director